Conmed Aktie

Conmed für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 886793 / ISIN: US2074101013

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
31.07.2025 04:28:55

Conmed Corp. Q2 Profit Decreases, But Beats Estimates

(RTTNews) - Conmed Corp. (CNMD) announced earnings for second quarter that Decreased from the same period last year but beat the Street estimates.

The company's bottom line came in at $21.42 million, or $0.69 per share. This compares with $29.98 million, or $0.96 per share, last year.

Excluding items, Conmed Corp. reported adjusted earnings of $35.61 million or $1.15 per share for the period.

Analysts on average had expected the company to earn $1.12 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 3.1% to $342.35 million from $332.10 million last year.

Conmed Corp. earnings at a glance (GAAP) :

-Earnings: $21.42 Mln. vs. $29.98 Mln. last year. -EPS: $0.69 vs. $0.96 last year. -Revenue: $342.35 Mln vs. $332.10 Mln last year.

-Guidance: Full year EPS guidance: $4.40 to $4.55 Full year revenue guidance: $1.356 B to $1.378 B

The company raised its full-year 2025 adjusted net earnings per share outlook to a range of $4.40 to $4.55 from the prior estimation of $4.31 to $4.46.

The company now projects full-year revenue to be between $1.356 billion and $1.378 billion, compared to the prior guidance $1.350 billion to $1.378 billion.

Analysen zu Conmed Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Conmed Corp. 40,20 3,08% Conmed Corp.